Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a proud post on Linkedin:
“Frailty in Haemophilia: A Hidden Challenge for Aging Patients.
New research reveals a concerning trend: People with haemophilia (PWH) face significantly higher rates of frailty compared to the general population—nearly 3x higher in those over 65.
Alarming frailty rates:
PWH aged 50-64: 17% have frailty vs. expected ~5%
PWH aged ≥65: 29% have frailty vs. 10% general population
This means PWH are aging like they’re 15+ years older
The ‘premature aging’ effect:
30% annual fall rate in PWH (~age 40)
Equivalent to general population >75 years
58% experience polypharmacy vs 45% in peers
The Geriatric Topics Affecting PWH:
- Falls and Immobility – chronic joint damage creates mechanical instability
- Cognitive Concerns – potential links to cerebral microbleeds under investigation
- Functional Incontinence – arthropathy limits timely toilet access
- Medication Overload – complex regimens for multiple conditions
Clinical Game-Changers:
- Clinical Frailty Scale screening to be recommended for all PWH >50
- Comprehensive Geriatric Assessment proven to reverse/slow frailty
- Novel care pathways needed: physiotherapy, occupational therapy, pharmacy optimization
This research highlights the urgent need for age-appropriate care pathways in haemophilia treatment centers. As our PWH population lives longer thanks to better treatments, we must address the unique challenges of aging with a bleeding disorder.”
Amazing review by Wolfgang Miesbach, read the full article here.
Title: Frailty and frailty syndromes in persons with haemophilia: a review
Authors: William McKeown, Stephanie Taylor, Susan Shapiro
Stay informed with Hemostasis Today.
-
May 30, 2026, 18:12Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
-
May 30, 2026, 18:11Alessandro Perrella: It is Not Only about “How High the CRP is”, but “in Which Patient” We are Measuring That Value
-
May 30, 2026, 18:11Jasper van Grunsven: Grateful for Our Rare Disease Team and the Commitment That Drives Our Mission
-
May 30, 2026, 18:10Open Registration for the 2026 Thrombosis Canada Annual Education Conference – Thrombosis Canada
-
May 30, 2026, 18:09Peter Zdziarski: Approval Does Not Mean NovoSeven is 100% Effective or Risk-Free in GT
-
May 30, 2026, 17:07Deepak Yadav: A Privilege to Talk on ESUS at CREST Stroke Conclave 2026
-
May 30, 2026, 16:59Syed A Rizvi: Medical Scoring Systems – Small Numbers, Big Clinical Decisions
-
May 30, 2026, 16:53Timothy “Tim” Sheehan: BNY Wealth Joins the Fight Against Blood Disorders In Support of Hemophilia of Georgia
-
May 30, 2026, 16:51Nouf Bahri: Anticoagulation Initiation for New-Onset Atrial Fibrillation in Critical Illness